Marco Sposito

495 total citations
38 papers, 233 citations indexed

About

Marco Sposito is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Marco Sposito has authored 38 papers receiving a total of 233 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 8 papers in Physiology. Recurrent topics in Marco Sposito's work include Cancer survivorship and care (11 papers), Lung Cancer Treatments and Mutations (10 papers) and Cancer Diagnosis and Treatment (7 papers). Marco Sposito is often cited by papers focused on Cancer survivorship and care (11 papers), Lung Cancer Treatments and Mutations (10 papers) and Cancer Diagnosis and Treatment (7 papers). Marco Sposito collaborates with scholars based in Italy, United States and France. Marco Sposito's co-authors include Michèle Milella, Alice Avancini, Sara Pilotto, Lorenzo Belluomini, Ilaria Trestini, Daniela Tregnago, Antônio Rossi, Emilio Bria, Federico Schena and Jessica Menis and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Marco Sposito

30 papers receiving 222 citations

Peers

Marco Sposito
Naoki Tashiro Japan
Christopher J. Schwartz United States
Jean-François Fléjou France
Pamela Correa Sweden
Evangelia Papavasileiou United States
Zengpanpan Ye China
Marta Solans Spain
Stefania Martini Italy
Naoki Tashiro Japan
Marco Sposito
Citations per year, relative to Marco Sposito Marco Sposito (= 1×) peers Naoki Tashiro

Countries citing papers authored by Marco Sposito

Since Specialization
Citations

This map shows the geographic impact of Marco Sposito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Sposito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Sposito more than expected).

Fields of papers citing papers by Marco Sposito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Sposito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Sposito. The network helps show where Marco Sposito may publish in the future.

Co-authorship network of co-authors of Marco Sposito

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Sposito. A scholar is included among the top collaborators of Marco Sposito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Sposito. Marco Sposito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tregnago, Daniela, Lucia Longo, Marco Sposito, et al.. (2025). Managing lorlatinib-induced weight gain through a structured exercise intervention in an ALK+ NSCLC patient: a case report. Frontiers in Oncology. 15. 1672319–1672319.
2.
Avancini, Alice, Marco Sposito, Daniela Tregnago, et al.. (2025). Impact of Long‐Term Structured Exercise on Body Composition in an NTRK Fusion‐Positive NSCLC Patient Treated With Entrectinib. Thoracic Cancer. 16(23). e70198–e70198.
3.
Belluomini, Lorenzo, Ilaria Trestini, Daniela Tregnago, et al.. (2025). Cardiac autonomic dysfunction in patients with cancer: exploring the role of physical exercise. Journal of Cancer Research and Clinical Oncology. 151(6). 197–197. 1 indexed citations
4.
Giannarelli, Diana, Ilaria Trestini, Daniela Tregnago, et al.. (2025). A cross-sectional study exploring the perception of exercise oncology in the Italian population. Frontiers in Oncology. 14. 1430083–1430083.
5.
Belluomini, Lorenzo, Ilaria Trestini, Daniela Tregnago, et al.. (2025). A Physical Exercise Intervention, Delivered Through In‐Person or Home‐Based Programs, in Patients Living With Cancer and Bone Metastases: A Single‐Arm, Feasibility Study. European Journal of Cancer Care. 2025(1). 2 indexed citations
6.
Belluomini, Lorenzo, Marco Sposito, Michèle Milella, et al.. (2024). What is the role of physical exercise in the era of cancer prehabilitation? A systematic review. Critical Reviews in Oncology/Hematology. 198. 104350–104350. 8 indexed citations
7.
Belluomini, Lorenzo, Alice Avancini, Ilaria Trestini, et al.. (2024). Implementation outcomes of early nutritional screening and referral for patients with thoracic cancers. Clinical Nutrition Open Science. 55. 168–172. 1 indexed citations
8.
Belluomini, Lorenzo, Alice Avancini, Marco Sposito, et al.. (2024). Integrating nutrition, physical exercise, psychosocial support and antiemetic drugs into CINV management: The road to success. Critical Reviews in Oncology/Hematology. 201. 104444–104444. 4 indexed citations
9.
Giannarelli, Diana, Lorenzo Belluomini, Ilaria Trestini, et al.. (2024). Exploring the Association between Health-Related Physical Fitness and Quality of Life in Patients with Cancer: A Cross-Sectional Study. Healthcare. 12(16). 1643–1643. 1 indexed citations
10.
Sposito, Marco, et al.. (2024). The frontier of neoadjuvant therapy in non-small cell lung cancer beyond PD-(L)1 agents. Expert Opinion on Biological Therapy. 24(10). 1025–1037. 1 indexed citations
11.
Ferrara, Miriam Grazia, Lorenzo Belluomini, Marco Sposito, et al.. (2023). Meta-analysis of the prognostic impact of TP53 co-mutations in EGFR-mutant advanced non-small-cell lung cancer treated with tyrosine kinase inhibitors. Critical Reviews in Oncology/Hematology. 184. 103929–103929. 14 indexed citations
12.
Belluomini, Lorenzo, Marco Sposito, Alice Avancini, et al.. (2023). Unlocking New Horizons in Small-Cell Lung Cancer Treatment: The Onset of Antibody–Drug Conjugates. Cancers. 15(22). 5368–5368. 19 indexed citations
13.
Sposito, Marco, Lorenzo Belluomini, Daniela Tregnago, et al.. (2023). Adjuvant Targeted Therapy in Solid Cancers: Pioneers and New Glories. Journal of Personalized Medicine. 13(10). 1427–1427. 2 indexed citations
14.
Avancini, Alice, Lorenzo Belluomini, Diana Giannarelli, et al.. (2023). Effect of exercise across the head and neck cancer continuum: a systematic review of randomized controlled trials. Supportive Care in Cancer. 31(12). 670–670. 13 indexed citations
15.
Sposito, Marco, Alice Avancini, Chiara Colato, et al.. (2023). Exceptional Response in BRAF p.V600E-Mutant Enteric-Type Adenocarcinoma of the Lung With Cutaneous Spread: A Case Report. JTO Clinical and Research Reports. 4(12). 100597–100597.
16.
Belluomini, Lorenzo, Alice Avancini, Marco Sposito, et al.. (2023). Antibody-drug conjugates (ADCs) targeting TROP-2 in lung cancer. Expert Opinion on Biological Therapy. 23(11). 1077–1087. 9 indexed citations
17.
Belluomini, Lorenzo, Alice Avancini, Marco Sposito, et al.. (2022). Selpercatinib in RET-fusion positive metastatic non-small cell lung cancer: achievements and gray areas. Expert Review of Anticancer Therapy. 22(8). 785–794. 4 indexed citations
18.
Avancini, Alice, Ilaria Trestini, Daniela Tregnago, et al.. (2022). Willingness, preferences, barriers, and facilitators of a multimodal supportive care intervention including exercise, nutritional and psychological approach in patients with cancer: a cross-sectional study. Journal of Cancer Research and Clinical Oncology. 149(7). 3435–3445. 8 indexed citations
19.
Trestini, Ilaria, Isabella Sperduti, Marco Sposito, et al.. (2020). Evaluation of nutritional status in non-small-cell lung cancer: screening, assessment and correlation with treatment outcome. ESMO Open. 5(3). e000689–e000689. 15 indexed citations
20.
Pilotto, Sara, Ilaria Trestini, Isabella Sperduti, et al.. (2020). 1831P Role of body composition (bc) in advanced non-small cell lung cancer (NSCLC) patients receiving first-line pembrolizumab (pembro). Annals of Oncology. 31. S1054–S1054. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Naoki Tashiro Breakdown of academic impact, for papers by Christopher J. Schwartz Breakdown of academic impact, for papers by Jean-François Fléjou Breakdown of academic impact, for papers by Pamela Correa Breakdown of academic impact, for papers by Evangelia Papavasileiou Breakdown of academic impact, for papers by Zengpanpan Ye Breakdown of academic impact, for papers by Marta Solans Breakdown of academic impact, for papers by Stefania Martini
Rankless by CCL
2026